Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

HIV and fatty liver: a hidden danger under the microscope

NCT ID NCT05023044

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 28 times

Summary

This study follows 400 adults with HIV to learn how nonalcoholic fatty liver disease (NAFLD) develops and progresses in this group. Researchers will use a non-invasive scan to measure liver stiffness and fat content over one year. The goal is to fill major knowledge gaps, since previous studies excluded people with HIV.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Duke University

    Durham, North Carolina, 27710, United States

  • Indiana University

    Indianapolis, Indiana, 46202, United States

  • Johns Hopkins University

    Baltimore, Maryland, 21287, United States

  • University of Alabama

    Birmingham, Alabama, 35233, United States

  • University of California, San Diego

    San Diego, California, 92121, United States

  • University of California, San Francisco

    San Francisco, California, 94143, United States

  • University of Texas

    Houston, Texas, 77030, United States

  • Virginia Commonwealth University

    Richmond, Virginia, 23284, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could reveal how NAFLD progresses in people with HIV, guiding future treatments and monitoring strategies.

What could go wrong

This is an observational study, not a treatment trial, so it won't directly improve health. Results may take years and might not apply to all HIV patients.

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease metabolic dysfunction-associated steatotic liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.